BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1270833)

  • 1. Cytophotometric studies of epidermal proliferation in psoriatic and normal skin.
    Grove GL; Anderton RL; Smith JG
    J Invest Dermatol; 1976 Apr; 66(4):236-8. PubMed ID: 1270833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the DNA content of basal and suprabasal keratinocytes in psoriatic patients.
    González S; Díaz F; Parrado C; Pérez de Vargas I
    J Cutan Pathol; 1993 Apr; 20(2):163-7. PubMed ID: 8320362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian rhythms and differences in epidermal and in dermal cel proliferation in uninvolved and involved psoriatic skin in vivo.
    Gelfant S; Ozawa A; Chalker DK; Smith JG
    J Invest Dermatol; 1982 Jan; 78(1):58-62. PubMed ID: 7054307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response to fluid injection in psoriatic and normal human epidermis.
    Grove GL
    Br J Dermatol; 1980 Mar; 102(3):281-3. PubMed ID: 6989385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal proliferation of uninvolved psoriatic epidermis: differential induction by saline, propranolol, and tape stripping in vivo.
    Wiley HE; Weinstein GD
    J Invest Dermatol; 1979 Dec; 73(6):545-7. PubMed ID: 512406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involved and uninvolved skin from psoriatic subjects: are they equally diseased? Assessment by skin transplanted to congenitally athymic (nude) mice.
    Krueger GG; Chambers DA; Shelby J
    J Clin Invest; 1981 Dec; 68(6):1548-57. PubMed ID: 7033288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.
    Wrone-Smith T; Mitra RS; Thompson CB; Jasty R; Castle VP; Nickoloff BJ
    Am J Pathol; 1997 Nov; 151(5):1321-9. PubMed ID: 9358758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of epidermal cell thymocyte-activating factor (ETAF) from cultured human keratinocytes from normal and uninvolved psoriatic skin.
    Kragballe K; Marcelo CL; Voorhees JJ; Sauder DN
    J Invest Dermatol; 1987 Jan; 88(1):8-10. PubMed ID: 3491857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.
    Abe J; Kondo S; Nishii Y; Kuroki T
    J Clin Endocrinol Metab; 1989 Apr; 68(4):851-4. PubMed ID: 2921314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray microanalysis of psoriatic skin.
    Grundin TG; Roomans GM; Forslind B; Lindberg M; Werner Y
    J Invest Dermatol; 1985 Oct; 85(4):378-80. PubMed ID: 4045225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial cultivation of epidermal keratinocytes from psoriatic plaques.
    Liu SC; Parsons CS
    J Invest Dermatol; 1983 Jul; 81(1):54-61. PubMed ID: 6863980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells.
    Demidem A; Taylor JR; Grammer SF; Streilein JW
    J Invest Dermatol; 1991 Sep; 97(3):454-60. PubMed ID: 1875046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel functional multiparameter flow cytometric assay to characterize proliferation in skin.
    Mommers JM; Goossen JW; van De Kerkhof PC; van Erp PE
    Cytometry; 2000 Feb; 42(1):43-9. PubMed ID: 10679742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a psoriatic skin model produced with involved or uninvolved cells.
    Jean J; Leroy M; Duque-Fernandez A; Bernard G; Soucy J; Pouliot R
    J Tissue Eng Regen Med; 2015 Jul; 9(7):789-98. PubMed ID: 23281213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis.
    Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
    J Exp Med; 1993 Oct; 178(4):1271-81. PubMed ID: 7690831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal epidermal cell proliferation on the elbow in psoriatic and normal skin.
    Galosi A; Pullmann H; Steigleder GK
    Arch Dermatol Res; 1980; 267(1):105-7. PubMed ID: 7387173
    [No Abstract]   [Full Text] [Related]  

  • 17. Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.
    MacLaughlin JA; Gange W; Taylor D; Smith E; Holick MF
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5409-12. PubMed ID: 2991921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis.
    Ishida-Yamamoto A; Senshu T; Takahashi H; Akiyama K; Nomura K; Iizuka H
    J Invest Dermatol; 2000 Apr; 114(4):701-5. PubMed ID: 10733676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased phospholipase C-catalyzed hydrolysis of phosphatidylinositol-4,5-bisphosphate and 1,2-sn-diacylglycerol content in psoriatic involved compared to uninvolved and normal epidermis.
    Fisher GJ; Talwar HS; Baldassare JJ; Henderson PA; Voorhees JJ
    J Invest Dermatol; 1990 Oct; 95(4):428-35. PubMed ID: 2170539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.
    van Erp PE; Rijzewijk JJ; Boezeman JB; Leenders J; de Mare S; Schalkwijk J; van de Kerkhof PC; Ramaekers FC; Bauer FW
    Am J Pathol; 1989 Nov; 135(5):865-70. PubMed ID: 2479273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.